Skip to main content
Log in

Volumetric assessment and clinical predictors of cirrhosis in patients undergoing hepatectomy for hepatocellular carcinoma with presumed normal liver function

  • Original Article
  • Published:
Hepatology International Aims and scope Submit manuscript

Abstract

Aim

Indocyanine green retention rate at 15 min (ICGR15) is a frequently used indicator of liver function. Herein, clinicopathological characteristics of cirrhotic patients with normal ICGR15 value (< 10%) were investigated, as these patients have risk of postoperative liver insufficiency when receiving a major hepatic resection.

Methods

Patients undergoing hepatectomy for hepatocellular carcinoma were divided into three groups: non-cirrhotic livers (Group A, n = 112): cirrhotic livers with ICGR15 < 10% (Group B, n = 71): and cirrhotic livers with ICGR15 > 10% (Group C, n = 296). Background characteristics and surgical outcomes were compared between groups. Functional liver volume (FLV) was computed using total liver volume and signal intensity ratio. Liver parenchymal cell volume ratio was measured in non-cancerous tissue obtained from resected specimens. Univariate and multivariate analyses were performed to detect clinical characteristics correlating with cirrhotic liver pathology with normal ICGR15.

Results

There was no significant difference between groups in TLV. FLV was gradually reduced from Group A toward Group C. Liver parenchymal cell volume ratio was also gradually reduced from Group A toward Group C. Multivariate analysis revealed that platelet count (< 12 × 104/mm3) (p = 0.001) and prothrombin time (< 80%) (p = 0.025) were significantly associated with cirrhotic liver pathology among patients with normal ICGR15.

Conclusion

Our results suggested that cirrhotic liver pathology despite normal liver function was characterized by slightly decreasing liver parenchyma as well as slight degree of fibrosis. Platelet count and PT% are useful for predicting liver cirrhosis with normal ICGR15.

Graphic abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Availability of data and materials

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Code availability

Not applicable.

Abbreviations

ARPI:

Aspartate aminotransferase-to-platelet ratio index

FIB-4:

Fibrosis-4

FLV:

Functional liver volume

Gd-EOB-DTPA:

Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid

HCC:

Hepatocellular carcinoma

ICG:

Indocyanine green

ICGR15:

Indocyanine green retention rate at 15 min

PT%:

Prothrombin time percentage

SI:

Signal intensity

TLV:

Total liver volume

References

  1. Kudo M, Izumi N, Kokudo N, Sakamoto M, Shiina S, Takayama T, et al. Report of the 21st nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res. 2021;51:355–405.

    Article  Google Scholar 

  2. Franco D, Capussotti L, Smadja C, Bouzari H, Meakins J, Kemeny F, et al. Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. Gastroenterology. 1990;98:733–738.

    Article  CAS  Google Scholar 

  3. Pimstone NR, Stadalnik RC, Vera DR, Hutak DP, Trudeau WL. Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog. Hepatology. 1994;20:917–923.

    Article  CAS  Google Scholar 

  4. Mahmoud M, Abdel-Kader R, Hassanein M, Saleh S, Botros S. Antipyrine clearance in comparison to conventional liver function tests in hepatitis c virus patients. Eur J Pharmacol. 2007;569:222–227.

    Article  CAS  Google Scholar 

  5. Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg. 2003;138:1198–1206 (discussion 1206).

    Article  Google Scholar 

  6. Seyama Y, Kokudo N. Assessment of liver function for safe hepatic resection. Hepatol Res. 2009;39:107–116.

    Article  Google Scholar 

  7. Lisotti A, Azzaroli F, Buonfiglioli F, Montagnani M, Cecinato P, Turco L, et al. Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. Hepatology. 2014;59:643–650.

    Article  CAS  Google Scholar 

  8. Lisotti A, Azzaroli F, Cucchetti A, Buonfiglioli F, Cecinato P, Calvanese C, et al. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh a cirrhosis and portal hypertension. Liver Int. 2016;36:1313–1321.

    Article  CAS  Google Scholar 

  9. Chang CC, Huang HC, Liu KL, Wu YM, Lee JJ, Jiang SF, et al. Clinical feasibility of GD-EOB-DTPA-enhanced MR imaging for assessing liver function: validation with ICG tests and parenchymal cell volume. Clin Imaging. 2016;40:797–800.

    Article  Google Scholar 

  10. Itoh S, Yoshizumi T, Shirabe K, Kimura K, Okabe H, Harimoto N, et al. Functional remnant liver assessment predicts liver-related morbidity after hepatic resection in patients with hepatocellular carcinoma. Hepatol Res. 2017;47:398–404.

    Article  Google Scholar 

  11. Araki K, Harimoto N, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, et al. Efficiency of regional functional liver volume assessment using GD-EOB-DTPA-enhanced magnetic resonance imaging for hepatocellular carcinoma with portal vein tumor thrombus. Surg Today. 2020;50(11):1496–1506.

    Article  CAS  Google Scholar 

  12. Yeom SK, Lee CH, Cha SH, Park CM. Prediction of liver cirrhosis, using diagnostic imaging tools. World J Hepatol. 2015;7:2069–2079.

    Article  Google Scholar 

  13. Liver Cancer Study Group of Japan: General Rules for the Clinical and Pathological Study of Primary Liver Cancer, ed 3. Tokyo, Kanehara & Co., Ltd., 2010.

  14. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis c. Hepatology. 2003;38:518–526.

    Article  Google Scholar 

  15. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with hiv/hcv coinfection. Hepatology. 2006;43:1317–1325.

    Article  CAS  Google Scholar 

  16. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32–35.

    Article  CAS  Google Scholar 

  17. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–213.

    Article  Google Scholar 

  18. Hashimoto M, Watanabe G. Hepatic parenchymal cell volume and the indocyanine green tolerance test. J Surg Res. 2000;92:222–227.

    Article  CAS  Google Scholar 

  19. de Graaf W, Hausler S, Heger M, van Ginhoven TM, van Cappellen G, Bennink RJ, et al. Transporters involved in the hepatic uptake of (99m)tc-mebrofenin and indocyanine green. J Hepatol. 2011;54:738–745.

    Article  Google Scholar 

  20. Huang L, Vore M. Multidrug resistance p-glycoprotein 2 is essential for the biliary excretion of indocyanine green. Drug Metab Dispos. 2001;29:634–637.

    CAS  PubMed  Google Scholar 

  21. Kawasaki S, Imamura H, Bandai Y, Sanjo K, Idezuki Y. Direct evidence for the intact hepatocyte theory in patients with liver cirrhosis. Gastroenterology. 1992;102:1351–1355

    Article  CAS  Google Scholar 

  22. Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg. 2005;12:16–22.

    Article  Google Scholar 

  23. Qiu Y, Hoshida Y, Kato N, Moriyama M, Otsuka M, Taniguchi H, et al. A simple combination of serum type iv collagen and prothrombin time to diagnose cirrhosis in patients with chronic active hepatitis c. Hepatol Res. 2004;30:214–220.

    Article  CAS  Google Scholar 

  24. Lurie Y, Webb M, Cytter-Kuint R, Shteingart S, Lederkremer GZ. Non-invasive diagnosis of liver fibrosis and cirrhosis. World J Gastroenterol. 2015;21:11567–11583.

    Article  CAS  Google Scholar 

  25. Pessaux P, Msika S, Atalla D, Hay JM, Flamant Y. Risk factors for postoperative infectious complications in noncolorectal abdominal surgery: a multivariate analysis based on a prospective multicenter study of 4718 patients. Arch Surg. 2003;138:314–324.

    Article  Google Scholar 

  26. Hackl C, Schlitt HJ, Renner P, Lang SA. Liver surgery in cirrhosis and portal hypertension. World J Gastroenterol. 2016;22:2725–2735.

    Article  CAS  Google Scholar 

  27. Beppu T, Hayashi H, Okabe H, Masuda T, Mima K, Otao R, et al. Liver functional volumetry for portal vein embolization using a newly developed 99mtc-galactosyl human serum albumin scintigraphy spect-computed tomography fusion system. J Gastroenterol. 2011;46:938–943.

    Article  Google Scholar 

  28. Sumiyoshi T, Okabayashi T, Negoro Y, Hata Y, Noda Y, Sui K, et al. (99m)tc-gsa spect/ct fusion imaging for hepatectomy candidates with extremely deteriorated icg value. Jpn J Radiol. 2018;36:537–543.

    Article  Google Scholar 

Download references

Funding

We received no funding/grant support for this study.

Author information

Authors and Affiliations

Authors

Contributions

Study concept and design, acquisition of data, analysis and interpretation of data, drafting of the manuscript, and statistical analysis: TS; study concept and design, acquisition of data, analysis and interpretation of data, and critical revision of the manuscript for important intellectual content: TA; study concept and design, and critical revision of the manuscript for important intellectual content: KK; acquisition of data: YN, KHP, TM, TS, YS, SM, and YI; statistical analysis: MI. All authors approved the final version of manuscript.

Corresponding author

Correspondence to Taku Aoki.

Ethics declarations

Conflict of interest

Takayuki Shimizu, Taku Aoki, Kyung‑Hwa Park, Takatsugu Matsumoto, Takayuki Shiraki, Yuhki Sakuraoka,·Shozo Mori, Yukihiro Iso, Mitsuru Ishizuka, Keiichi Kubotas declare no conflict of interests for this article.

Ethical approval

Our study was approved by the Institutional Review Board (provided ID number: R-8-14) on the basis of the Ethical Guidelines for Clinical Research of the Ministry of Health, Labor and Welfare in Japan prior to its initiation.

Consent to participate

We provided the enrolled patients with the opportunity to opt out on our website www2.dokkyomed.ac.jp/dep-m/surg2/pg334.html().

Consent for publication

Not applicable.

Animal research

Not applicable.

Clinical trials registration

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOC 47 KB)

Supplementary file2 (DOC 47 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shimizu, T., Aoki, T., Park, KH. et al. Volumetric assessment and clinical predictors of cirrhosis in patients undergoing hepatectomy for hepatocellular carcinoma with presumed normal liver function. Hepatol Int 15, 1258–1267 (2021). https://doi.org/10.1007/s12072-021-10246-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-021-10246-y

Keywords

Navigation